SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-22-000023
Filing Date
2022-05-11
Accepted
2022-05-11 17:09:44
Documents
69
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tars-20220331.htm   iXBRL 10-Q 1076568
2 EX-10.1 exhibit101-loanandsecurity.htm EX-10.1 519502
3 EX-10.2 exhibit102-consultingagree.htm EX-10.2 65087
4 EX-31.1 exhibit311-33122.htm EX-31.1 12774
5 EX-31.2 exhibit312-33122.htm EX-31.2 13030
6 EX-32.1 exhibit321-33122.htm EX-32.1 9965
7 EX-32.2 exhibit322-33122.htm EX-32.2 9907
  Complete submission text file 0001819790-22-000023.txt   6188977

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20220331.xsd EX-101.SCH 41217
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20220331_cal.xml EX-101.CAL 75784
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20220331_def.xml EX-101.DEF 152303
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20220331_lab.xml EX-101.LAB 497154
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20220331_pre.xml EX-101.PRE 318520
63 EXTRACTED XBRL INSTANCE DOCUMENT tars-20220331_htm.xml XML 831391
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 22914668
SIC: 2836 Biological Products, (No Diagnostic Substances)